www.fdanews.com/articles/101001-novavax-losses-rise-on-r-38-d-costs
Novavax Losses Rise on R&D Costs
November 13, 2007
Novavax Inc. saw losses rise 80 percent last quarter as it spent more money developing experimental influenza vaccines.
Washington Business Journal